Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,488 | -873 | -6,065 | -2,137 | -1,450 |
| Depreciation Amortization | 30 | 14 | 44 | 33 | 23 |
| Income taxes - deferred | -101 | -48 | -367 | -242 | -173 |
| Accounts receivable | -259 | -116 | 3 | 1 | 2 |
| Accounts payable and accrued liabilities | 9 | -37 | -98 | N/A | 94 |
| Other Working Capital | 30 | 234 | 2,077 | 702 | 415 |
| Other Operating Activity | 382 | 228 | 3,506 | 475 | 132 |
| Operating Cash Flow | $-1,397 | $-600 | $-901 | $-1,168 | $-958 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -18 | -18 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | -156 | N/A | N/A |
| Other Investing Activity | -3 | 0 | 0 | 314 | 109 |
| Investing Cash Flow | $-21 | $-18 | $-156 | $314 | $109 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,000 | 1,000 | 181 | 132 | 382 |
| Debt Issued | 160 | 313 | 1,011 | 692 | 606 |
| Debt Repayment | -479 | -470 | -295 | -157 | -177 |
| Common Stock Issued | 531 | 531 | N/A | N/A | N/A |
| Other Financing Activity | 519 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,732 | $1,374 | $897 | $667 | $812 |
| Exchange Rate Effect | 0 | -2 | -4 | -3 | -4 |
| Beginning Cash Position | 243 | 243 | 407 | 407 | 350 |
| End Cash Position | 556 | 997 | 243 | 217 | 309 |
| Net Cash Flow | $314 | $755 | $-164 | $-190 | $-41 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,397 | -600 | -901 | -1,168 | -958 |
| Free Cash Flow | -1,397 | -600 | -901 | -1,168 | -958 |